CHICAGO -- Semaglutide (Ozempic) reduced glucose levels and weight among patients with type 1 diabetes and obesity, a ...

The term sheet was signed in the presence of senior officials from BIRAC, the department of biotechnology, and industry ...

Amgen (NASDAQ:AMGN) announced on Monday that its new weight loss treatment, MariTide, resulted in an average weight loss of ...

Historic changes are afoot for pharma as China gains ground on U.S. production. The pharma industry is projected to see ...

A new drug called amycretin has shown it can help reduce body weight in two early-phase clinical trials. The drug, which ...

Novo Nordisk has ended its partnership with Hims & Hers Health Inc., citing “deceptive marketing” and the selling of ...

Amgen is expanding development plans for its weight-loss drug MariTide to study its use for heart disease and sleep apnea.

The pharmaceutical company alleges Hims is widely selling cheaper versions of its blockbuster drugs, despite the FDA's recent ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.

An article published in the journal Nature Metabolism presents an experimental drug that stimulates adipose tissue cells to ...